Unknown

Dataset Information

0

A far downstream enhancer for murine Bcl11b controls its T-cell specific expression.


ABSTRACT: Bcl11b is a T-cell specific gene in hematopoiesis that begins expression during T-lineage commitment and is required for this process. Aberrant expression of BCL11B or proto-oncogene translocation to the vicinity of BCL11B can be a contributing factor in human T-ALL. To identify the mechanism that controls its distinctive T-lineage expression, we corrected the identified Bcl11b transcription start site and mapped a cell-type-specific differentially methylated region bracketing the Bcl11b promoter. We identified a 1.9-kb region 850 kb downstream of Bcl11b, "Major Peak," distinguished by its dynamic histone marking pattern in development that mirrors the pattern at the Bcl11b promoter. Looping interactions between promoter-proximal elements including the differentially methylated region and downstream elements in the Major Peak are required to recapitulate the T-cell specific expression of Bcl11b in stable reporter assays. Functional dissection of the Major Peak sequence showed distinct subregions, in which TCF-1 sites and a conserved element were required for T-lineage-specific activation and silencing in non-T cells. A bacterial artificial chromosome encompassing the full Bcl11b gene still required the addition of the Major Peak to exhibit T-cell specific expression. Thus, promoter-proximal and Major Peak sequences are cis-regulatory elements that interact over 850 kb to control expression of Bcl11b in hematopoietic cells.

SUBMITTER: Li L 

PROVIDER: S-EPMC3739036 | biostudies-literature | 2013 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

A far downstream enhancer for murine Bcl11b controls its T-cell specific expression.

Li Long L   Zhang Jingli A JA   Dose Marei M   Kueh Hao Yuan HY   Mosadeghi Ruzbeh R   Gounari Fotini F   Rothenberg Ellen V EV  

Blood 20130605 6


Bcl11b is a T-cell specific gene in hematopoiesis that begins expression during T-lineage commitment and is required for this process. Aberrant expression of BCL11B or proto-oncogene translocation to the vicinity of BCL11B can be a contributing factor in human T-ALL. To identify the mechanism that controls its distinctive T-lineage expression, we corrected the identified Bcl11b transcription start site and mapped a cell-type-specific differentially methylated region bracketing the Bcl11b promote  ...[more]

Similar Datasets

| S-EPMC8563395 | biostudies-literature
| S-EPMC4369408 | biostudies-literature
| S-EPMC6324936 | biostudies-literature
| S-EPMC4868469 | biostudies-literature
| S-EPMC4756855 | biostudies-literature
| S-EPMC395199 | biostudies-other
| S-EPMC10832512 | biostudies-literature
| S-EPMC3676467 | biostudies-literature
| S-EPMC2657370 | biostudies-literature
| S-EPMC6685970 | biostudies-literature